|Year : 2015 | Volume
| Issue : 3 | Page : 346-350
Anticancer activity of Arkeshwara Rasa - A herbo-metallic preparation
Md Nafiujjaman1, Md Nurunnabi2, Samir Kumar Saha3, Rownak Jahan3, Yong-kyu Lee2, Mohammed Rahmatullah3
1 Department of Green Bioengineering, Korean National University of Transportation, Chungju, Republic of Korea
2 Department of Polymer Science and Engineering, Korean National University of Transportation, Chungju, Republic of Korea
3 Department of Pharmacy, University of Development Alternative, Dhaka, Bangladesh
|Date of Web Publication||20-May-2016|
Department of Pharmacy, University of Development Alternative, Dhaka - 1207
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Introduction: Though metal based drugs have been prescribed in Ayurveda for centuries to treat various diseases, such as rheumatoid arthritis and cancer, toxicity of these drugs containing heavy metal is a great drawback for practical application. So, proper scientific validation of herbo-metallic drugs like Arkeshwara Rasa(AR) have become one of the focused research arena of new drugs against cancers. Aim: To investigate the in vitro anticancer effects of AR. Materials and Methods: Anticancer activity of AR was investigated on two human cancer cell lines, which represent two different tissues (pancreas and skin). Lactate dehydrogenase (LDH) assay for enzyme activity and trypan blue assay for cell morphology were performed for further confirmation. Results: AR showed potent activity against pancreatic cancer cells (MIA-PaCa-2). LDH activity confirmed that AR was active against pancreatic cancer cells. Finally, it was observed that AR exhibited significant effects on cancer cells due to synergistic effects of different compounds of AR. Conclusion: The study strongly suggests that AR has the potential to be an anticancer drug against pancreatic cancer.
Keywords: Anticancer, Arkeshwara Rasa, natural products
|How to cite this article:|
Nafiujjaman M, Nurunnabi M, Saha SK, Jahan R, Lee Yk, Rahmatullah M. Anticancer activity of Arkeshwara Rasa - A herbo-metallic preparation. AYU 2015;36:346-50
|How to cite this URL:|
Nafiujjaman M, Nurunnabi M, Saha SK, Jahan R, Lee Yk, Rahmatullah M. Anticancer activity of Arkeshwara Rasa - A herbo-metallic preparation. AYU [serial online] 2015 [cited 2021 Jul 25];36:346-50. Available from: https://www.ayujournal.org/text.asp?2015/36/3/346/182757
| Introduction|| |
Ayurveda is considered as the most ancient form of traditional medicine in the Indian sub-continent, dating back to more than 3500 years. The basic distinction between Ayurveda and other traditional medicinal systems are availability of several therapeutic approaches. Regarding that, Ayurveda had its origin in Atharva Veda, which consist of various important topics including human health, engineering, and astrology. In China, the Chinese traditional medicinal system is advancing through promoting its therapies through research and evidence-based approaches. Similarly, it is essential to study the stage-wise transformations that take place during the preparation of Ayurvedic medicines along with the characterization of final product(s). This will assist to define the chemical nature of Ayurvedic medicines apart from understanding the role of various constituents added during various preparation steps., This traditional form of medicine relies on medicinal plants for treatment; however, use of other materials like metals in the form of metallic salts, herbo-metallic complexes, and ashes (”Bhasma” or calcined form of the metal) have also been reported. A particular category of Ayurvedic herbo-metallic formulation known as “Rasa” is particularly noted for using metals and even heavy metals in these formulations. Rasas are used for treatment of various complex disorders, such as diabetes, rheumatoid arthritis, cancer, etc., For instance, Tarakeshwara Rasa is used for treatment of diabetes. Tarakeshwara Rasa contains calcined forms of tin, biotite and iron, as well as mercury in the form of mercuric sulfide or black sulfide of mercury along with other plant products. Although scientists have expressed concerns on the use of heavy metals in the formulations and possible resultant toxicity, Ayurvedic practitioners insist that calcinations or use of metals such as mercury in particularly their sulfide form abolishes metal toxicity.
Among the hundreds of Rasas used by Ayurvedic practitioners, Arkeshwara Rasa (AR), consisting of a number of plant parts together with mercuric sulfide, is used for treatment of rheumatoid arthritis. Various plant parts used in AR include dried and powdered fruit rind of Terminalia belerica Roxb. (Combretaceae), Terminalia chebula Retz. (Combretaceae), and Phyllanthus emblica L (Euphorbiaceae). These fruit rinds are used along with whole plants of Plumbago zeylanica L. (Plumbaginaceae) and latex of Calotropis procera (Aiton) W.T. Aiton (Apocynaceae). The preparation of AR is a complex process. Ayurvedic practitioners insist that although the formulation is administered orally, there are no adverse side-effects.
It is interesting that the plants or plant parts used in AR have reported anticancer properties. Triphala composed of three fruits show potent anticancer activity and also individual fruits show that they have antitumor activity in vitro and in vivo, respectively., Mercuric sulfide (HgS) is a component of traditional mineral medicine, which has been used as a memory-enhancing drug for more than thousands of years. Though mercury is known to be toxic in living tissues, salts form of mercury have been traditionally considered nontoxic. Researchers reported that mercury sulfide in traditional medicine has 5000 times less mercury than organic methyl mercury. The efficacy and safety aspects of mercurial preparations have been assessed. Traditional medicinal books of Ayurveda and Chinese traditional medicine insist that mercury, minerals and plants or animal products are very useful in cancers. It was therefore of interest to study the anticancer effectiveness of AR against various cancer cell lines and evaluate any mercuric sulfide (an ingredient of AR)-induced toxicity in the same cell lines.
| Materials and Methods|| |
Mercury and sulfur were obtained from Sigma Chemical Co., USA. Plant materials were obtained from Bangladesh after proper identification and authentication by the Medicinal Plant Collection Wing of the University of Development Alternative. Arkeshwara Rasa was prepared exactly as previously described by Bhagvatacharya in a classical Ayurvedic text Rasa Ratna Samucchoy. In this process, one part mercury was thoroughly mixed with two parts sulfur in an earthen vessel. The vessel was covered with a circular copper lid, and leakages were sealed with clay. The whole vessel was then covered with live coals for 6–7 h. The lid was then taken off and mercuric sulfide deposited on the lower part of the lid scraped off. Collected mercuric sulfide was then powdered and mixed with latex of C. procera and decoction of Triphala (fruits of P. emblica, T. belerica and T. chebula) with P. zeylanica whole plants. The mixture was boiled for a few hours to dryness and then boiled again with fresh latex of C. procera and decoction of Triphala with P. zeylanica whole plants to dryness. This was done a total of 10 times and final product was obtained as powder.
In vitro cell cytotoxicity
Human pancreatic cancer cells MIA-PaCa-2 and epithelial carcinoma KB cells were used to determine the cell viability of AR. MIA-PaCa-2 and KB cells were collected from Korea Cell Bank (Seoul, Korea). Both cells were cultured at 37°C in a humidified atmosphere containing 5% CO2 in FA-deficient medium RPMI 1640 with 10% fetal bovine serum. The cells (5 × 106 cells/mL) were grown as a monolayer and harvested with 0.25% trypsin in 0.03% ethylene di-amine tetra acetic acid solution, followed by the seeding of 200 µL of each cell type in 96-well plates and preincubation for 24 h. To investigate the selectivity and cytotoxicity of AR, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was performed on both cells. Cells were incubated at 37°C for 24 h; the control was incubated without any drug. Three different concentrations (10, 100, and 500 µg/mL) of each compound were tested. MTT assay is based on the reduction of a yellow tetrazolium component to an insoluble purple-colored formazan produced by the mitochondria of viable cells. After incubation for 24 h, 100 µL of medium containing 20 µL of MTT solution (MTT, USA) were added to each well. The plate was then incubated for an additional 4 h, followed by the addition of 180 µL of MTT solubilization solution (10% Triton X-100 plus 0.1 N HCl in anhydrous iso-propanol (Sigma, Milwaukee, USA) to each well. The solution was gently mixed to dissolve MTT formazan crystals. The absorbance of each well was measured with a micro plate reader at 570 nm.
Trypan Blue dye exclusion test
Cell viability of AR was determined by cell morphology using Trypan Blue dye exclusion test. Following treatments, cell cultures were in situ stained with 0.2% Trypan Blue solution (Sigma, USA) at room temperature for 10 min and then fixed with Trypan Blue dye at 4°C. The fixed cultures were rinsed with phosphate-buffered saline and examined under light microscopy at ×10 magnification. Cultures from all treatment conditions were photographed using Zeis microscope.
Lactate dehydrogenase assay
Lactate dehydrogenase (LDH) test-kit (CytoTox 96® NonRadioactive Cytotoxicity Assay, Promega Co.) was used to investigate the cell membrane integrity as per the procedure described in the kit. The absorbance at 490 nm was recorded on a Microplate Reader (Varioskan Flash). The LDH leakage (% of positive control) is expressed as the percentage of (test-blank)/(positive-blank), where test is the cells exposed to the AR, positive is the optical density of the positive control cells and blank is the optical density of the wells without cells.
Statistical differences were performed using a one-way ANOVA (Origin Pro 8.0). Data were presented as mean ± SEM. P < 0.05 were considered as statistically significant.
| Results|| |
In vitro anticancer activity
A herbo-metallic Ayurvedic drug (AR) was investigated to evaluate its potential therapeutic efficacy against cancer cells.In vitro cytotoxicity of the drug was examined by MTT cell viability against different human cancer cell lines like, human epidermal carcinoma (KB) cells and human pancreatic cancer (MIA-PaCa2) cells with medium used as control. Cells were treated with different concentrations (10, 100, 500 µg/mL) of AR. After treatment with drugs, MIA-PaCa2 cells showed lower cell viability of about 20% compared with the control where medium was used as control (IC50 values about 333.33 µg/mL). Cell viability decreased with increasing AR concentrations and reached almost 20% at higher concentration of drug (500 µg/mL). In contrast, the other cancer cell, KB cells did not show any significant effects (55% cell viability at 500 µg/mL concentration) like pancreatic cells [Figure 1]. It is possible that AR may contain one or more component(s), to which pancreatic cancer cells are more sensitive.
|Figure 1: Cell cytotoxicity assay against Arkeshwar Rasa. (a) Cell viability assay of human epidermal carcinoma cells about 55% at 500 μg/mL concentration. (b) Cell viability assay of human pancreatic cancer cells about 25% at higher concentration. (c) Comparison between two cells viability of cells against herbal drugs|
Click here to view
To examine cell viability, in situ Trypan Blue dye exclusion test to detect live cells and dead cells was performed. This is a stain that identifies nonviable cells, which absorb dye when observed under a microscope, while viable cells appear unstained. Viable cells have intact cell membranes and so cannot uptake the dye. In contrast, nonviable cells do not have an intact and functional membrane and hence do take up dye from their surroundings. As such, Trypan Blue can easily differentiate between viable and nonviable cells. Cell viability decreased with increasing concentrations of AR. Overall, as evidenced by the morphological data, exposure to 0.5 μg/mL AR for 24 h resulted in more pancreatic cancer cell's death than epithelial carcinoma cells [Figure 2].
|Figure 2: Cell morphology assay against Arkeshwar Rasa with different concentrations of MIA-PacA-2 cells (left) and KB cells (right)|
Click here to view
Lactate dehydrogenase release activity
LDH is an enzyme which exists in a variety of organisms, including plants and animals and can be measured as a surrogate for tissue breakdown. For the LDH release assay, dose dependent activity was observed when MIA-PaCa-2 and KB cells were exposed to AR. Indicative cytotoxicity was observed from 10 to 500 μg/mL when both cells were exposed to AR. 10 μg/mL concentration of resulted in 90% of KB cells and 55% of MIA-PaCa-2 cells increase of LDH leakage in comparison to controls, respectively. Increasing the concentration of AR further increased release of LDH. At 500 μg/mL, AR exposure resulted in almost 75% release of LDH in MIA-PaCa-2 cells and 95% in KB cells [Figure 3].
|Figure 3: In vitro lactate dehydrogenase release study of (a) KB cells; (b) MIA-PaCa-2 cells|
Click here to view
| Discussion|| |
Herbal medicines have been widely recognized and scientists emphasize the importance and urgency of examining potential drug interactions produced by natural products. We investigated the mercuric sulfide based herbo-metallic preparation commonly known as AR, which demonstrated potent anticancer activity in a human pancreatic cancer cell line through cell viability and enzymatic activity assays. AR is composed of Triphala with P. zeylanica and fresh latex of C. procera along with mercuric sulfide. Researchers have found that Triphala itself as well as the plants individually show cytotoxic activity in cancer cells. One group of researcher reported the differential response of normal and tumor cells to Triphala in vitro, and the substantial regression of transplanted tumor in mice fed with Triphala points to its potential use as an anticancer drug for clinical treatment. Another group reported that Triphala was more potent on pancreatic cancer in vivo and in vitro, respectively. The studies suggest that Triphala may consist of one or more components, which are more potent on pancreatic cancer cells. A study has shown that extracts of raw fruits of P. emblica at 50–100 µg/mL significantly inhibited cell growth of human cancer cell lines. Extracts of fruits of T. chebula demonstrated cytotoxic activity in a number of cell lines like human (MCF-7) and mouse (S115) breast cancer cell line, a human osteosarcoma cell line (HOS-1), a human prostate cancer cell line (PC-3) and a nontumorigenic, immortalized human prostate cell line (PNT1A) by inhibiting the rate of cell proliferation and inducing cell death. Methanolic extracts of T. belerica fruits with others enhancer has been shown to reduce cancer in mice. Choedon et al. reported that it showed potent activity against hepato-carcinogenesis in mice with no side-effects. Methanolic extracts of C. procera induced extensive cell death in both Huh-7 and COS-1 cells but not in AML12 cells. Ethanolic extract of P. zeylanica Linn. has been shown to possess significant anticancer activity and also reduced elevated level of lipid peroxidation due to the extract's higher content of terpenoids and flavonoids., Thus the various plant ingredients of AR have been variously reported to have anticancer activity, and together they might have produced the anticancer effect in the present study. However, individual component(s) of each plant having anticancer effects need to be identified, which is currently under progress in our laboratory.
In Ayurveda, mercuric sulfide is considered nontoxic when prepared as described in the methods section and the process of heating mercury to form mercuric sulfide results in formation of ash. In Ayurveda it is claimed that the process of preparing mercuric sulfide (calcinations) results in abolition of the toxicity of mercury, and enhancing its quality so that it is effectively used by the body. In herbo-metallic preparations, the metal (in this case mercury) is transformed from a heavy, hard and rough structure to a light, soft and smooth powder (Bhasma) and the macro-sized particles are reduced to their nano form (usually 10–50 nm) as established by modern microscopic and spectroscopic techniques. It still remains to be firmly established that such herbo-metallic preparations containing mercury have no toxic effects in the body, although our results suggest that mercury in its sulfide form did not produce any toxicity. A recent study has also claimed that herbo-metallic preparations (i.e., preparations containing metals along with herbal components, which together may or may not be in a complex form) as well as Bhasmas are safe to use. Thus, AR can be considered as a potential promising anticancer agent.
| Conclusions|| |
The findings indicate that human pancreatic cancer cells are highly sensitive against AR as measured through growth inhibition and LDH release activity. This anticancer activity can be due to the presence of various anticancer phytochemicals present in the various plant ingredients in combination with mercuric sulfide.
Financial support and sponsorship
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0021427).
Conflicts of interest
There are no conflicts of interest.
| References|| |
Subbarayappa BV. The roots of ancient medicine: An historical outline. J Biosci 2001;26:135-43.
Valiathan MS. An Ayurvedic view of life. Curr Sci 2009;96:1186-92.
Patwardhan B, Warude D, Tillu G. Heavy metals and Ayurveda. Curr Sci 2005;88:1535-6.
Balaji K, Brindha P, Sridharan K, Uma MK, Swaminathan S, Rajan KS. Elucidation of a core-shell model for Lauha Bhasma through physico-chemical characterization. Int J Pharm Pharm Sci 2012;4:644-9.
Kamath SU, Pemiah B, Sekar RK, Krishnaswamy S, Sethuraman S, Krishnan UM. Mercury-based traditional herbo-metallic preparations: A toxicological perspective. Arch Toxicol 2012;86:831-8.
Virupaksha GK, Kumar N. Characterization of Tarakeshwara rasa
: An Ayurvedic herbomineral formulation. Ayu 2012;33:406-11.
Frawley D. Ayurvedic Healing - A Comprehensive Guide. Lotus Press: Twins Lake; 2000.
Bhagvatacharya M. In: Sengupta KD, Sengupta KU, editors. Rasa Ratna Samucchoy. 2nd
ed. Kolkata, Dwipayan, 20 Keshab Chandra Sen Street, Kolkata, India; 2008. p. 2-3.
Shi Y, Sahu RP, Srivastava SK. Triphala
inhibits both in vitro
and in vivo
xenograft growth of pancreatic tumor cells by inducing apoptosis. BMC Cancer 2008;8:294.
Sandhya T, Lathika KM, Pandey BN, Mishra KP. Potential of traditional Ayurvedic formulation, Triphala
, as a novel anticancer drug. Cancer Lett 2006;231:206-14.
Liu J, Shi JZ, Yu LM, Goyer RA, Waalkes MP. Mercury in traditional medicines: Is cinnabar toxicologically similar to common mercurials? Exp Biol Med (Maywood) 2008;233:810-7.
Singh SK, Chaudhary A, Rai DK, Rai SB. Preparation and characterization of a mercury based Indian traditional drug: Ras-Sindoor. Indian J Tradit Knowl 2009;8:346-51.
Nurunnabi M, Khatun Z, Nafiujjaman M, Lee DG, Lee YK. Surface coating of graphene quantum dots using mussel-inspired polydopamine for biomedical optical imaging. ACS Appl Mater Interfaces 2013;5:8246-53.
Choi DW. Ionic dependence of glutamate neurotoxicity. J Neurosci 1987;7:369-79.
Jeune MA, Kumi-Diaka J, Brown J. Anticancer activities of pomegranate extracts and genistein in human breast cancer cells. J Med Food 2005;8:469-75.
Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW. Interactions of herbs with cytochrome P450. Drug Metab Rev 2003;35:35-98.
Ngamkitidechakul C, Jaijoy K, Hansakul P, Soonthornchareonnon N, Sireeratawong S. Antitumour effects of Phyllanthus emblica
L.: Induction of cancer cell apoptosis and inhibition of in vivo
tumour promotion and in vitro
invasion of human cancer cells. Phytother Res 2010;24:1405-13.
Das ND, Jung KH, Park JH, Mondol MA, Shin HJ, Lee HS, et al. Terminalia chebula
extract acts as a potential NF-?B inhibitor in human lymphoblastic T cells. Phytother Res 2011;25:927-34.
Kumudhavalli M, Mohit VV, Jayakar B. Phytochemical and pharmacological evaluation of the plant fruit of Terminalia belerica
Roxb. Int J Pharm Life Sci 2010;1:1-11.
Choedon T, Mathan G, Arya S, Kumar VL, Kumar V. Anticancer and cytotoxic properties of the latex of Calotropis procera
in a transgenic mouse model of hepatocellular carcinoma. World J Gastroenterol 2006;12:2517-22.
Hiradeve S, Danao K, Kharabe V, Mendh B. Evaluation of anticancer activity of Plumbago zeylanica
Linn leaf extract. Int J Biomed Res 2010;1:1-9.
Raihan MO, Brishti A, Tareq SM, Khalequeuzzaman M, Islam MF, Hossain MA. Plumbago zeylanica
L. Root induced apoptosis of Ehrlich ascites carcinoma cell. Am J Drug Discov Dev 2012;2:124-34.
Kumar G, Gupta YK. Evidence for safety of Ayurvedic herbal, herbo-metallic and Bhasma
preparations on neurobehavioral activity and oxidative stress in rats. Ayu 2012;33:569-75.
[Figure 1], [Figure 2], [Figure 3]
|This article has been cited by|
||Herbometallic nano-drug inducing metastatic growth inhibition in breast cancer through intracellular energy depletion
| ||Bhuban Ruidas,Tapas Kumar Sur,Kunal Pal,Sutapa Som Chaudhury,Parash Prasad,Koel Sinha,Prasanta Kumar Sarkar,Pritha Das,Chitrangada Das Mukhopadhyay |
| ||Molecular Biology Reports. 2020; 47(5): 3745 |
|[Pubmed] | [DOI]|
||HgS Inhibits Oxidative Stress Caused by Hypoxia through Regulation of 5-HT Metabolism Pathway
| ||Qiangqiang He,Ji Ma,Praveen Kumar Kalavagunta,Liangliang Zhou,Junyi Zhu,Jing Dong,Owais Ahmad,Yuzhi Du,Lixin Wei,Jing Shang |
| ||International Journal of Molecular Sciences. 2019; 20(6): 1364 |
|[Pubmed] | [DOI]|
||A novel herbometallic nanodrug has the potential for antibacterial and anticancer activity through oxidative damage
| ||Bhuban Ruidas,Sutapa Som Chaudhury,Kunal Pal,Prashanta Kumar Sarkar,Chitrangada Das Mukhopadhyay |
| ||Nanomedicine. 2019; |
|[Pubmed] | [DOI]|
||Assessment of antioxidant, antimicrobial and anti-osteosarcoma potential of four traditionally used Indian medicinal plants
| ||Debasis Nayak,Sarbani Ashe,Pradipta Ranjan Rauta,Bismita Nayak |
| ||Journal of Applied Biomedicine. 2016; |
|[Pubmed] | [DOI]|